Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Edge Biotechnologies ApS
APS
Active
CVR 44985977
Spurvevej 10, 2970
Hørsholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2024 · 1 year old
2 employees
www.edgebiotechnologies.com
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Edge Biotechnologies ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
0M
-1M
-1M
2025: 0M
0M
2025
EBITDA
DKK millions
0M
0M
0M
-1M
-1M
2025: 0M
0M
2025
Income statement
DKK thousands
Item
2025
Gross profit
11
Staff expenses
-110
EBITDA
-98
Depreciation & amort.
-0
EBIT
-98
Net financials
-5
Profit before tax
-104
Tax
-0
Net profit
-104
Balance sheet
DKK thousands
Item
2025
Total assets
138
Equity
-54
Long-term debt
110
Short-term debt
82
Total debt
192
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-875,7 %
This company
2025
2025
Equity ratio
-38,8 %
This company
38,2 %
Market median
This company
Market median
202% below market
2025
2025
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2025
2025
Net profit margin (of gross profit)
-923,0 %
This company
2025
2025
Asset turnover (of gross profit)
0,08×
This company
2025
2025
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-07-30 – 2025-12-31
View
PDF
More on Edge Biotechnologies ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
